Live cell superresolution-SIM imaging analysis of the intercellular transport of microvesicles and costimulatory proteins via nanotubes between immune cells by Halasz, Henriett et al.
Methods and Applications in Fluorescence
ACCEPTED MANUSCRIPT
Live cell superresolution-SIM imaging analysis of the intercellular
transport of microvesicles and costimulatory proteins via nanotubes
between immune cells
To cite this article before publication: Henriett Halasz et al 2018 Methods Appl. Fluoresc. in press https://doi.org/10.1088/2050-6120/aad57d
Manuscript version: Accepted Manuscript
Accepted Manuscript is “the version of the article accepted for publication including all changes made as a result of the peer review process,
and which may also include the addition to the article by IOP Publishing of a header, an article ID, a cover sheet and/or an ‘Accepted
Manuscript’ watermark, but excluding any other editing, typesetting or other changes made by IOP Publishing and/or its licensors”
This Accepted Manuscript is © 2018 IOP Publishing Ltd.
 
During the embargo period (the 12 month period from the publication of the Version of Record of this article), the Accepted Manuscript is fully
protected by copyright and cannot be reused or reposted elsewhere.
As the Version of Record of this article is going to be / has been published on a subscription basis, this Accepted Manuscript is available for reuse
under a CC BY-NC-ND 3.0 licence after the 12 month embargo period.
After the embargo period, everyone is permitted to use copy and redistribute this article for non-commercial purposes only, provided that they
adhere to all the terms of the licence https://creativecommons.org/licences/by-nc-nd/3.0
Although reasonable endeavours have been taken to obtain all necessary permissions from third parties to include their copyrighted content
within this article, their full citation and copyright line may not be present in this Accepted Manuscript version. Before using any content from this
article, please refer to the Version of Record on IOPscience once published for full citation and copyright details, as permissions will likely be
required. All third party content is fully copyright protected, unless specifically stated otherwise in the figure caption in the Version of Record.
View the article online for updates and enhancements.
This content was downloaded from IP address 142.132.1.147 on 25/07/2018 at 14:27
 1 
 
Live cell superresolution-SIM imaging analysis of the 
intercellular transport of microvesicles and costimulatory 
proteins via nanotubes between immune cells 
 
 
Halász, Henriett1,+, Ghadaksaz, Ali Reza1,2,+, Madarász, Tamás1, Huber, Krisztina2, 
Harami, Gábor3, Tóth, Eszter Angéla2, Osteikoetxea-Molnár, Anikó2, Kovács, 
Mihály3, Balogi, Zsolt5, Nyitrai, Miklós1,4, Matkó, János2,*, Szabó-Meleg, 
Edina1,4,* 
 
 
1Department of Biophysics, Medical School, University of Pécs, Szigeti street 12, H-7624, Pécs, 
Hungary  
2Department of Immunology, and 3Department of Biochemistry, Faculty of Science, Eötvös 
Loránd University, Pázmány Péter street 1/C, H-1117 Budapest, Hungary 
4Szentágothai Research Center, University of Pécs, Ifjúság street 20, H-7624, Pécs, Hungary 
5Department of Biochemistry & Medical Chemistry, University of Pecs, Medical School 
 H-7624 Szigeti str. 12, Pecs, Hungary 
 
 
 
 
 
 
*Corresponding authors: Janos Matko PhD, DSc (matko@elte.hu) and Szabo-Meleg Edina, 
PhD  (edina.meleg@aok.pte.hu )  
 
+ The authors equally contributed to the project  
 
 
 
 
 
 
 
 
 
 
Keywords: membrane nanotubes, SR-SIM imaging, microvesicle transport, microtubule, actin 
filaments, motor proteins, lymphocytes, macrophages   
 
 
Running title: intercellular transport of microvesicles and CD86 via nanotubes assessed by 
superresolution microscopy 
 
 
 
 
 
Page 1 of 20 AUTHOR SUBMITTED MANUSCRIPT - MAF-100432.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
 2 
 
 
ABSTRACT:  
 
Membrane nanotubes are transient long-distance connections between cells that can facilitate 
intercellular communication. These tethers can form spontaneously between many cell types, 
including cells of the immune and nervous systems. Traffic of viral proteins, vesicles, calcium 
ions, mRNA, miRNA, mitochondria, lysosomes and membrane proteins/raft domains have all 
been reported so far via the open ended tunneling nanotubes (TNTs). Recently we reported on 
existence of plasma membrane derived GM1/GM3 ganglioside enriched microvesicles and 
costimulatory proteins in nanotubes connecting B lymphocytes, the way they are formed and 
transported across TNTs, however, still remained unclear. Here, using live cell confocal and 
Structured Illumination (SR-SIM) superresolution imaging, we show that B cells respond to 
bacterial (Cholera) toxin challenge by their subsequent internalization followed by rapid 
formation of intracellular microvesicles (MVs). These MVs are then transported between 
adjacent B cells via nanotubes. Selective transport-inhibition analysis of two abundant motor 
proteins in these cell types demonstrated that actin-based non-muscle myosin 2A dominantly 
mediates intercellular MV-transport via TNTs, in contrast to the microtubule-based dynein, as 
shown by the unchanged transport after inhibition of the latter. As suggested by SR-SIM 
images of GFP-CD86 transfected macrophages, these costimulatory molecules may be 
transferred by unusually shaped MVs through thick TNTs connecting macrophages. In contrast, 
in B cell cultures the same GFP-CD86 is dominantly transported along the membrane wall of 
TNTs. Such intercellular molecule-exchange can consequently improve the efficiency of 
antigen-dependent T cell activation, especially in macrophages with weak costimulator 
expression and T cell activation capacity. Such improved T cell activating potential of these 
two cell types may result in a more efficient cellular immune response and formation of 
immunological memory. The results also highlight the power of superresolution microscopy 
to uncover so far hidden structural details of biological processes, such as microvesicle 
formation and transport. 
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1. INTRODUCTION 
 
Membrane nanotubes (NTs), thin and long cellular protrusion structures connecting cells, were 
first described more than a decade ago (Onfelt, Nedvetzki et al. 2004, Rustom, Saffrich et al. 
2004). Since then, a number of interesting functional capabilities of these nanostructures have 
been described, such as intercellular signaling/Ca2+ transfer and transport of protein molecules, 
prions, vesicles, membrane cargos, nucleic acids or even organelles (Davis and Sowinski 2008, 
Gerdes and Carvalho 2008, Gurke, Barroso et al. 2008, Sherer and Mothes 2008, Davis 2009). 
 NTs show high diversity in length, thickness and structure (Austefjord et al. 2014). 
Concerning their thickness, they are usually characterized as „thin” (~100-300 nm diameter) 
or ‘thick’ (~400-1000 nm diameter) nanotubes. In vitro they always contain actin filaments (F-
actin), and the thick NTs often contain microtubules, as well. 
Smaller entities, like prions or viruses were reported to be transported across any types 
of NTs, while transport of larger vesicles and organelles or ‘surfing’ of bacteria were reported 
mainly through the surface or interior of the thick, open-ended, so called ‘tunneling nanotubes’ 
(TNTs) (Onfelt, Nedvetzki et al. 2006, Gerdes, Bukoreshtliev et al. 2007, Osteikoetxea-Molnar, 
Szabo-Meleg et al. 2016). After exploring membrane nanotubes, cells of the nervous and 
immune systems were studied most deeply, including among others macrophages, neurons, 
astrocytes, T cells, NK cells and their targets. In addition, functional significance of nanotubes 
in bridging tumor cells has been nicely demonstrated recently and now it represents a new 
research line with continuously increasing high medical interest (Lou, Fujisawa et al. 2012, 
Osswald, Jung et al. 2015, Ady, Thayanithy et al. 2016, Lou 2016).  
We have shown recently that mature B lymphocytes also contain microtubules in their 
thick, tunneling nanotubes, which are able to transport organelles, such as mitochondria or 
lysosomes, as well (Osteikoetxea-Molnar, Szabo-Meleg et al. 2016). Critical importance of 
membrane lipids (among others of gangliosides/ glycosphingolipids or cholesterol) in NT-
formation were also reported recently (Delage and Zurzolo 2013, Toth, Oszvald et al. 2017). 
In spite of this continuously accumulating knowledge on membrane nanotubes, many 
questions about the mechanism and regulation of their formation, the direction of their growth, 
as well as their functional significance in vivo  (Seyed-Razavi et al. 2013, Caneparo et al. 2011; 
Osswald et al. 2015; Rehberg et al. 2016; Saenz-de-Santa-Maria et al. 2017; Teddy and Kulesa 
2004; Vignais et al. 2017) still remained open, although the latter publications firmly support 
that the nanotubes may exist and function in various in vivo environments.  
In the present study we focused on revealing the intercellular transport properties of B 
cells’ and macrophages’ nanotubes, as a continuation of our recent work on basic mechanistic 
properties of B cell nanotube formation (Osteikoetxea-Molnar, Szabo-Meleg et al. 2016, Toth, 
Oszvald et al. 2017). Here we investigated the formation and transport of intracellular (IC)  
microvesicles (MVs) after challenging immature (unable to form nanotubular bridges) or 
mature (with high capacity to form nanotubular networks) B lymphocyte cells with bacterial 
toxin, the Cholera toxin B subunit (CTX-B) binding with high selectivity/affinity to GM1/GM3 
gangliosides at the cell surface. This process tried to model an in vivo often appearing event, 
the interaction of bacterial toxins with B cell surface.  
Using Alexa488-CTX-B and time-lapse live cell confocal (CLSM) and SR-SIM 
imaging we intended to understand how the ganglioside/CTX-B-enriched microvesicles (MV) 
(or multivesicular bodies; MVB) are formed and how are they transported through the 
tunneling nanotubes connecting B cells. We also investigated how the membrane ganglioside 
level correlates with formation of such intracellular MVs. Particularly, we were also interested 
in the mechanism of their transport, namely what type of motors proteins are involved in this 
process. 
Page 3 of 20 AUTHOR SUBMITTED MANUSCRIPT - MAF-100432.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
c
pt
d M
an
us
cri
pt
 4 
CD86 is one of the essential B7-family costimulatory proteins expressed on various 
antigen presenting cells (such as dendritic cells, B cells or macrophages) that play a key role 
in amplifying TCR-dependent T cell activation/cellular immune response, independently of 
the quantitative aspects of TCR-antigen recognition. Therefore, CD86 may critically set the 
magnitude of T-cell mediated cellular immune response through providing an additional 
‘second signal’ upon binding to their CD28 receptors on T cells (Janakiram, Abadi et al. 2012). 
Monitoring intercellular trafficking of GFP-CD86 in transfected B cells and 
macrophages, utilizing advantages of SR-SIM imaging (Vangindertael, Camacho et al. 2018) 
revealed that this essential costimulatory molecule can be exchanged among both cell types. 
In B cells it is transported mostly in the membrane wall of nanotubes, while in macrophages 
dominantly via large, elongated ‘microvesicle-like’ structures, inside the TNTs. Clarification 
of the nature of such mobile intracellular CD86 compartments, however, needs further detailed 
investigations. Our results, also demonstrating power of superresolution microscopy 
(Vangindertael, Camacho et al. 2018) over confocal microscopy to reveal structural details of 
biological processes, such as microvesicle transport, shed light on some new mechanistic 
details of the nanotube-mediated cellular communication between cells of the immune system.    
 
 
2. EXPERIMENTAL DETAILS  
 
2.1. Cells, culture and labeling.  
B cells of murine origin with two different stages of maturation/differentiation were used in 
this study, A20 mature B cells (ATCC TIB208, I-Ad/Ed+) and 38C13 immature B cells (Caspi, 
Taya et al. 1995). These murine B and macrophage (RAW 264.7; ATCC® TIB-71™) cell lines, 
were cultured in RPMI-1640 medium, supplemented with 2 mM L-glutamine, 1mM Na-
pyruvate, 50 µM 2-mercaptoethanol, antibiotics and 10% FCS, and were kept at 37°C in 5% 
CO2 incubator. Expression of cell markers during tissue culture were continuously checked 
using immunocytochemical labeling and BD FACSAria III flow cytometer (BD, San Jose, CA, 
USA).  
 
2.2. Reagents, cell transfection & treatments  
Fibronectin (Sigma-Aldrich, St. Louis, MO, USA) was used as optimal ECM support 
(Osteikoetxea-Molnar, Szabo-Meleg et al. 2016) for studying B cells in live cell imaging 
chamber. 
Alexa488/Alexa647-Cholera toxin B were purchased from Life Technologies (Carlsbad, USA).  
Ciliobrevin D, specific inhibitor of dynein motor proteins were from Sigma-Aldrich. P-nitro-
blebbistatin, inhibitor of non-muscle myosin 2A (Kepiro, Varkuti et al. 2014) was purchased 
from Optopharma Ltd (Hungary). For live cell CD86 experiments, RAW246.7 murine 
macrophages and A20 murine B lymphocytes were electroporated by Amaxa Nucleofector IIb 
device (programs T-020 and L-013 were used, respectively) according to the manufacturer’s 
instruction. Briefly, for each sample the mixture of 87 µl of nucleofector solution and 19 µl of 
supplement was prepared and added to the cells together with 2 µl GFP-CD86 DNA construct 
(pCMV6-AC-GFP; OriGene Technologies, Rockville, MD, USA). The transfected cells were 
then passaged into a fibronectin coated glass petri dish and incubated overnight (37°C, 5% 
CO2). A pCMV6-AC-GFP vector with no insert was used as control in the experiments. To 
visualize endogenous CD86 cells were fixed with 4% paraformaldehyde (PFA) for 10 min, at 
room temperature, then permeabilized with 0.1% Triton X-100+5% BSA (Sigma-Aldrich, St. 
Louis, MO, USA) for 20 min at RT and incubated with CD86 (B7-2) monoclonal antibody 
(GL1, BD Biosciences, Franklin Lakes, NJ, USA) for 1 h at RT. After washing step the cells 
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were incubated with donkey anti-rat biotinylated secondary antibody (Jackson 
ImmunoResearch Europe Ltd. UK) for 24 hrs at 4°C in 0.05% thimerosal (Sigma-Aldrich, St. 
Louis, MO, USA) containing blocking solution  then after 4 hrs incubation with the ABC 
complex (Vectastain® Elite® ABC-HRP Kit, Vector Laboratories, Burlingame, USA) the 
signal was amplified by Alexa594-conjugated tyramide (Thermo Fisher Scientific, Waltham, 
MA, USA) and H2O2 (Sigma-Aldrich, St. Louis, MO, USA) for 10 min at RT, finally cells 
were mounted in Vectashield (Vector Laboratories, Burlingame, CA, USA) medium. To 
visualize Caveolin-1 RAW 264.7 macrophages were first labelled with anti-Cav-1 monoclonal 
antibody for 30 min at RT, then goat anti-mouse Alexa555 was used as secondary antibody 
after the previously mentioned fixation and permeabilization procedures (see above). Anti-
Cav-1 primary and anti-mouse Alexa555 secondary antibodies were the kind gift of Prof. Anna 
L. Kiss (Semmelweis University, Faculty of Medicine, Department of Anatomy, Histology and 
Embryology, Budapest, Hungary). 
 
2.3. Quantitative measurement of NT growth and vesicle transport with live cell imaging  
Borosilicate bottomed chambers (P35G-0.170-14-C MatTek In Vitro Life Science 
Laboratories, Bratislava, Slovak Republic) were coated (or not) with 10 g/ml fibronectin 
overnight to model physiological circumstances; temperature was controlled at 37±0.1°C, CO2 
was controlled at 5%. 106 cells/well were incubated at these conditions for 1 hour. The number 
of NT-growing cells were counted in each fields, while the fluorescently labelled microvesicles 
were counted in the nanotubes, as mobile ones or not, depending on their average displacement 
obtained from their motion trajectories, using SR-SIM imaging and Zeiss ZEN software. 
Images were analysed with FIJI software (NIH, Bethesda, MD, USA), for velocity calculation 
the MultipleKymograph plugin of FIJI 
(https://www.embl.de/eamnet/html/body_kymograph.html) was used. ImageJ/TrackMate 
plugin was used to identify and then track vesicle movement between cells via TNTs. 
 
2.4. Microscopic Imaging  
Nanotube formation was visualized with Zeiss LSM 710 Confocal Laser Scanning Microscope 
(CLSM) at 63x magnification (oil immersion objective; N.A.: 1.4). For imaging nanotube 
growth, the cells were labelled with Alexa488 or Alexa 647conjugated CTX–B membrane 
ganglioside-specific probes at 40 µg/ml concentration (cells were incubated on ice for 20 min, 
in the presence of fluorescently labelled CTX). Cells were then washed once with PBS buffer 
and once with RPMI+10% FCS+mercaptoethanol medium and placed on the 10 g/ml 
fibronectin coated (overnight) microchambers. Records were taken and analyzed with the Zen 
black software and further analyzed using Image J (FIJI; Wayne Rashband, NIH, Washington, 
USA) and occasionally Imaris 8.2 (Bitplane, Zürich, Switzerland) softwares. Superresolution 
(dlat:~80-90 nm) SR-SIM imaging was performed in a Zeiss Elyra S1 (63x; N.A.:1.4 objective) 
microscope system with live cell imaging conditions. Images were acquired with five grid 
rotations and analyzed with the ZEN (Black or Blue versions) software. 
 
2.5. Statistical analysis 
Occurrence frequencies were calculated from at least 20 images/sample (~40-50 cells/field; 
~800 cells/sample) and given as mean ± SD. The frequency of nanotube forming cells were 
calculated as a ratio of cells growing at least one nanotube per all cells visible in the particular 
field. The number of mobile vesicles/nanotube value was determined on the basis of their 
motion trajectories recorded in a 10 min interval from at least three independent cell samples 
(ca. 50 NTs/sample). The image analysis and the statistical calculations, including significance 
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tests (using Student t-test), were made with ImageJ/FIJI and SigmaPlot 10.0 or Origin 8.0 
statistical softwares, respectively.  
 
 
 
 
2.6. Flow cytometry and trypan blue quenching experiments 
 
A20 lymphocytes’ pellets were incubated with 40 µg/ml Alexa488-conjugated CTX-B on ice 
for 20 min Control samples were kept on ice without dyes added. Samples were washed twice 
at 4°C, then pellets were re-suspended in pre-warmed PBS and incubated at 37°C for 2 min or 
30 min to allow and facilitate CTX-B internalization.  Samples were then placed on ice and 
immediately analyzed for green fluorescence (BPF 530/30) by a BD FACS Canto II flow 
cytometer (BD, San Jose, CA, USA). Cell debris and dead cells were excluded from the 
analysis based on FSC (forward scatter) vs. SSC (side scatter) dot plot and gating. Extracellular 
Alexa488-CTX signal was quenched by adding 0.04 % of cell impermeable dye trypan-blue 
(Thermo Fisher Scientific, Waltham, MA, USA), hence fluorescence intensities of the re-
measured samples were representative of internalized signal. Data were analyzed by FACS 
DIVA 6.0 software (BD, San Jose, CA, USA), and displayed as relative mean of fluorescence 
normalized to unstained control cells.  
For live cell SR-SIM imaging A20 B lymphocytes were treated with 0.1% trypan-blue dye for 
2 minutes after Alexa488-CTX labeling (see above). To visualize the quenching effect of 
trypan-blue on Alexa dye labeling CD86, A20 lymphocytes were first labelled with anti-CD86 
monoclonal antibody (GL1, BD Biosciences, Franklin Lakes, USA) for 30 min at RT, then 
goat anti-rat Alexa488 (Thermo Fisher Scientific, Waltham, MA, USA) was used as secondary 
antibody. The cells were washed twice and Trypan-blue was added in 0.1% concentration to 
quench the fluorescence of the Alexa488 dye. 
 
3. RESULTS  
 
3.1. Challenging B cells’ plasma membrane with Cholera toxin B results in rapid formation of 
intracellular microvesicles detected by SR-SIM 
 
Since immature (38C13) and mature (A20) murine B cells are substantially different in their 
capacity to form nanotubes (Osteikoetxea-Molnar, Szabo-Meleg et al. 2016), first we 
compared here their response to bacterial toxin. Cells were incubated with Alexa488-Cholera 
toxin B subunit known to bind to GM1/GM3 gangliosides in the plasma membrane of cells 
(similarly to various enterotoxins). 30 min after addition, small, spherical microvesicles (MVs) 
could be detected in both cell types, although in largely different extent, under live cell imaging 
conditions, at 37°C and 5% CO2 (Fig. 1A-D), using SR-SIM imaging. Notice that immature B 
cells (38C13) formed much less ganglioside-rich vesicles (and more slowly) than the mature 
B cells (A20) did (Fig. 1E). Concerning the ganglioside-rich microvesicles, we found that they 
form in the cytoplasm rapidly after internalization (formation saturates in ca. 30 min) (Fig. 1E) 
and are very heterogenous in size, in a range of ~200-1000 nm (see e.g. Fig. 3D).  
We should note here that the lateral resolution of CLSM (Schermelleh, Heintzmann et 
al. 2010) was not sufficient enough to resolve clearly these microvesicles and determine their 
size- or velocity-distribution. SR-SIM imaging, however, with dlat: ~80-90 nm provided a 
sufficient lateral (x-y) resolution to do that (see: Supplementary Fig. 1).  
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Figure 1. Cholera toxin B challenge of B cells results in formation of intracellular microvesicles. Representative 
SR-SIM images of 38C13 immature (A,B) and A20 mature (C,D) murine B cells are shown 5 and 30 min after 
CTX-B stimulation, respectively. The fluorescence originates from membrane bound Alexa488-CTX-B 
molecules. The quantitative difference between MV formation in immature and mature B cells, respectively, is 
shown in panel E, where the mean number of intracellular vesicles/cell is displayed in time. Data at each time 
point are displayed as mean +/- SD of 3-4 independent experiments (including ca. 30-50 cells/sample).  
 
 
3.2. Characterization of the ganglioside-rich MVs of B cells  
 
The fact that the intercellular conduits connecting B lymphocytes contain GM1/GM3 
ganglioside-rich microvesicles has already been reported by us, recently (Osteikoetxea-Molnar, 
Szabo-Meleg et al. 2016). While confocal microscopy with its dlat: 240 nm resolution could 
not resolve smaller individual microvesicles formed and transported inside and between cells, 
SR-SIM imaging could nicely overcome this limitation (Supplementary Fig.1). The improved 
resolution is remarkably visible at the ‘growth cone’-like structure of the TNTs at the interfaces 
with the cell membranes of the two adjacent B lymphocytes. Here the CLSM can show only a 
patchy and blurry fluorescence picture, while SR-SIM draws sharply contrasted (fluorescent), 
membrane covered, small globular vesicle structures. This means that applying live cell SR-
SIM imaging, there is a good chance to monitor the mechanistic details of the intercellular 
MV-transport.  
 Upon challenging B cells with Alexa488-Cholera-toxin B (40 μg/ml) we observed 
formation of small intracellular vesicles shown in Figure 1. Internalization of this fluorescent 
ligand bound to their cell surface GM1/GM3 ganglioside receptors was monitored 
quantitatively by flow cytometry (Fig. 2A-D) and also demonstrated by SR-SIM microscopy 
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(Fig. 3A,B). Trypan-blue quenching of surface bound (extracellular) fluorescence could 
sensitively discriminate it from the intracellular fluorescence with robust statistical value in 
flow cytometry (Patino, Soriano et al. 2015). B cells gated by the forward vs. side scatter 
diagram (Fig. 2A) show significantly higher fluorescence in the absence (Fig. 2B) than in the 
presence of trypan-blue (TB) (Fig. 2C and D) at both 2 and 30 minutes after CTX 
administration. At shorter times (2 min) however, the extent of the quenching was much higher 
than that of at longer times (30 min) (Fig. 2D). This clearly demonstrates that the 
internalization is continuously running and saturates in ca. 30 minutes after addition of the 
bacterial toxin. These observations are further confirmed by the SR-SIM images showing 
similar effects of trypan-blue quenching (Fig. 3A,B). These representative images demonstrate 
that while the intracellular, internalized vesicle fluorescence does not change upon TB addition, 
the fluorescence at the plasma membrane got highly reduced (see yellow arrowheads).  
Fig. 3C shows a representative image of mature A20 B cells 30 min after CTX-B 
challenge, where IC MVs already appeared. These cells were re-stained with Alexa647-CTX-
B at this time (middle image). A merge of the two images (right), demonstrates coexistence of 
plasma membrane and intracellularly localized ganglioside-CTX-B complexes/MVs in the 
same cell. As shown by a representative line scan diagram (Fig. 3D), the majority of these 
intracellular microvesicles have 200-500 nm diameter. Some larger (ca. 2-4 times as large) 
vesicular structures could also be observed (see also in (Osteikoetxea-Molnar, Szabo-Meleg et 
al. 2016). These are supposed to be multivesicular bodies (MVBs), appearing in a small 
number. Their detailed characterization needs further investigations.   
 
 
 
 
Figure 2.  Internalization of surface bound CTX-B as monitored by flow cytofluorimetry. 
The forward scatter (FSC) vs. side scatter (SSC) diagram of the B lymphocyte (A20) sample and the gating 
protocol for selecting live, intact B cells is shown on panel A. Panels B and C show representative flow cytometric 
fluorescence histograms of Alexa488-CTX challenged A20 B lymphocytes in the absence or presence of trypan-
blue quencher (0.04%), respectively. Statistics of flow cytometric experiments performed with or without trypan-
blue at 2 minutes or 30 minutes after Alexa488-CTX-B administration is shown on D. Each flow cytometric 
records were made of at least 20.000 cells and the mean and SD values displayed in Fig.2D were determined from 
3 independent experiments. (The differences in Fig. 2D are significant at the level of p < 0.05) 
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Figure 3.  Internalization and properties of CTX-B enriched microvesicles in B cells. 
SR-SIM microscopic images of B cells (Fig. 3A and B) clearly show that 30 min after CTX-B challenge addition 
of trypan-blue (0.1%) largely quenched the plasma membrane associated CTX-B fluorescence, while the internal 
fluorescence was left unchanged. Coexistence of plasma membrane localized and intracellular MV-localized 
CTX-B fluorescence is shown on Fig. 3C. Fluorescence originated from the cell surface labeling with Alexa488-
CTX-B (green) is shown 30 min after administration of CTX-B to the B cell culture (left). These cells at this time 
point were re-stained with Alexa647 (red) (see middle image); merged image of the two is shown right. Panel D 
shows a representative SR-SIM BW image of a B cell in which the microvesicles are well resolved. A line scan 
analysis shows the intensity distribution along the scanning line in X direction. From this analysis the approximate 
size (diameter) of the individual vesicles can be estimated.  
 
 
3.3 Intercellular transport of ganglioside-rich MVs between B cells and macrophages: actin-
dependent myosin 2A but not dynein mediates this process 
 
The live cell SR-SIM technology allowed us to record motional trajectories of single 
microvesicles and thus to analyze their transport properties across tunneling nanotubes 
bridging lymphocytes and macrophages (Supplementary Movie 1). The Alexa488-CTX-
stained vesicles were shown to be transported to the neighboring cells (Fig. 4). Existence of 
such MVs in the intercellular conduits between B cells has already been shown by us 
(Osteikoetxea-Molnar, Szabo-Meleg et al. 2016), however their motional characteristics have 
not been analyzed, yet. A two color (green-red; Alexa488 vs. Alexa647), CTX-B labelled 
mixed culture of B cells was created in order to demonstrate the real intercellular exchange of 
vesicles. Nanotube formation and the exchange was analyzed by live cell CLSM with 63x 
magnification (or sometimes with monocolor superresolution SIM imaging). As Fig. 4A shows 
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the vesicles formed in a mixed culture of green and red labelled B cells indeed arrive into the 
‘target cells’. The Supplementary Movie 2 convincingly demonstrates using a superior 
tracking analysis that a vesicle formed in a B cell (upper; ‘donor cell’) is transported via the 
intercellular NT bridge into another B cell (lower; ‘acceptor cell’). A single microvesicle is 
typically transferred in ca. 16 min through the TNT. During a 2 hrs interval in culture, allowing 
live cell imaging without significant cell death, an actual intercellular exchange of 2-3 
microvesicles in average (mean+/-SD: 2+/-2, from 49 independent fields of view) was 
observed between the B cells connected with NT conduits. Fig. 4B shows a section of a TNT 
connecting two B cells (upper part) and this region is zoomed in below (lower part). Fig. 4C 
is a similar zoomed image showing such moving CTX-B+-microvesicles in a TNT bridging 
two RAW264.7 macrophage cells.  
 As shown in Fig. 4D both B and macrophage cells can transport these microvesicles 
efficiently, since the percentage of mobile vesicles in TNTs were relatively high (ca. 80 and 
58%, respectively). Their motion in live cell time-lapse SR-SIM images was analyzed on the 
basis of their kymographic trajectories and found relatively diverse (Fig. 4E). Their average 
velocity in the nanotubes was found ca. 15±3 nm/sec. Such velocity suggests that the process 
is likely not free diffusion, but rather mediated by a motor protein-cytoskeletal track system.  
Non-muscle myosin 2A (NM2A) motor protein is abundantly expressed in lymphocytes 
(Osteikoetxea-Molnar, Szabo-Meleg et al. 2016), such as dynein, which is also a functionally 
essential motor protein in B cells, involved among others in internalization of the antigen 
receptor, BCR (Schnyder, Castello et al. 2011). So, next we investigated using live cell time-
lapse SR-SIM imaging, whether inhibition of activities of these motor proteins can affect or 
not the transport of MVs across TNTs. Inhibition of microtubule associated dynein motor 
protein activity by ciliobrevin D (up to 20 μM concentration) did not affect the transport of 
MVs, even after 20 minutes incubation (Fig. 4F and Supplementary Movies 1, 3). In the same 
time window, inhibition of myosin 2A, an actin-dependent motor protein, by p-nitro-
blebbistatin (already at 40 μM concentration), however, significantly blocked the motion of 
these vesicles in the tubules (Fig. 4F and Supplementary Movies 1, 4).  
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Figure 4.  Traffic of ganglioside/CTX enriched microvesicles between B cells and macrophages.  
The MVs formed after ganglioside/CTX-B internalization are transported across the TNTs grown under live cell 
conditions. The time lapse panel (A) is a series of representative CLSM images demonstrating this transport 
between two adjacent A20 murine B cells (total time: ca.16 min; for the actual position of the moving green 
vesicle, see the yellow arrowheads). Trajectory of the green-labelled vesicle moving from the donor to the 
recipient B cell via TNT can be seen in Supplementary Movie 2. Panel B shows zooming into a region of such 
B cells’ TNTs (arrowheads point on individual MVs). A similar representative zoomed image of transported 
microvesicles along a TNT connecting RAW 264.7 macrophages is shown on panel C. Panel D demonstrates a 
relatively high mobility of intracellular MVs in both A20 B cells and RAW 264.7 macrophages. As shown in 
panel E, the mobile vesicles move with a highly diverse velocity, in the range of 0.6 to 200 nm/sec. Velocity 
distribution of microvesicles in the tubes was determined by analyzing their kymographic trajectories (FIJI 
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software MultipleKymograph plugin). Data showing the percentage of mobile vesicles/TNT revealed that 
treatment of B cell cultures with selective inhibitor of dynein motor protein (Ciliobrevin-D, at 20 M) did not 
influence, but with the inhibitor of actin-based myosin 2A motor protein (p-nitro-blebbistatin, at 40 M) 
significantly blocked the transport of such MVs (Fig. 4F). The mean +/- SD values of mobile vesicle % in TNTs 
determined from three independent experiments (ca. 20-30 TNTs in each samples) are displayed. (These 
inhibition experiments can also be seen in Supplementary Movies 3-4, with control, untreated cells on 
Supplementary Movie 1).  
 
3.4. Transport of B7 family costimulatory molecules between TNT-connected B lymphocyte or 
macrophage cells  
 
The actual membrane level of CD86 and CD80 B7-family proteins in B cells and especially in 
macrophages (where they have typically lower expression) essentially determines the capacity 
of these cells to activate helper or cytotoxic/killer T cells and the subsequent cellular immune 
response (Nurieva, Liu et al. 2009). Thus, it is an intriguing question whether these potential 
antigen-presenting cells can exchange CD86 costimulatory molecules via intercellular 
transport through nanotubular bridges. Recently we have shown existence of both MHC-II-
peptide complexes and CD86 costimulatory membrane proteins in the nanotubes connecting 
adjacent B cells (Osteikoetxea-Molnar, Szabo-Meleg et al. 2016).  
 To investigate redistribution/motion of CD86 costimulatory molecules, in the present 
study we made fluorescent GFP-CD86 constructs and transfected them into murine B (A20) 
and macrophage (RAW 264.7) cells. Then, we analyzed spatial distribution of these fluorescent 
CD86 constructs and the way they are transported between two B or two macrophage cells.  
 Since both cell types constitutively express endogenous CD86, as well, although at 
different level (macrophages express significantly less CD86), first we tried to visualize how 
the transfected green fluorescent CD86 relates spatially to the endogenous CD86 stained by 
red immunocytochemical (antibody) labeling using permeabilization/fixation of the cells. In B 
cells (Fig. 5A) the endogenous CD86 (red) shows a more dispersed distribution in the 
cytoplasm (reflecting also CD86+ intracellular vesicles in which they are transported to the 
plasma membrane after their synthesis) than in macrophages where their synthesis/expression 
is much lower (Fig. 5B). In both cells the transfected GFP-CD86 (green) mostly appears in the 
plasma membrane or in macrophages rarely in large vesicular compartments (Fig. 5A, B and 
D).  
 Since it also remained an open question whether in B cells or macrophages these CD86 
costimulatory transmembrane proteins can be associated or not with the ganglioside-rich CTX-
B+-microvesicles mentioned earlier, next we investigated how the transfected green CD86 
molecules relate spatially to the red-CTX-B marked ganglioside-rich microvesicles. As Fig. 
5C and D show, there is some level of colocalization between the MVs and the GFP-CD86 
(see arrowheads), while some disparate, heavily loaded CD86 compartments (large 
‘microvesicle-like’ structures) could also be observed, but only in macrophages (Fig. 5D). This 
suggests that in B cells and macrophages the intracellular compartmentation and trafficking of 
the transfected GFP-CD86 proteins may be largely different.  In macrophages we investigated 
by immunocytochemical staining of Caveolin-1, a specific structural protein and widely 
accepted marker of caveolas, whether the transfected CD86 is compartmented in caveolas. As 
shown in Fig. 5E,F no colocalization is observed between the GFP-CD86 molecules and the 
red colored antibody labeling caveolin-1, suggesting that the GFP-CD86 complexes are not 
internalized with Cav-mediated pathways (Pearson colocalization coefficient: -0,05867+/-
0,21603). As a control, Fig. 5G shows that if the endogenous CD86 is labelled extracellularly 
by antibody (green, in the middle) in B cells (DIC image on left), we see an intensive 
membrane labeling that can be fully quenched by 0.1% trypan blue (TB) (right).  
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 Interestingly enough, the intercellular transport of GFP-CD86 in B cells and 
macrophages showed a highly different picture. In mature B cells the CD86 transmembrane 
protein seemed to be transported intercellularly in the membrane of the tunneling nanotubes, 
rather than in the interior of TNTs (Fig. 5I and Supplementary Movie 5). In contrast, in 
macrophages, the GFP-CD86 seems to be localized in large ‘microvesicle-like’ compartments 
inside the cells, and their intercellular transport also takes place in such elongated (ca. 3-4 µm 
long and 0.7-0.8 µm thick) structures (Fig. 5H, J and Supplementary Movie 6). Whatever is 
the exact mechanism of the transport, our results point out that both B cells and macrophages 
are able to exchange B7-family costimulatory proteins via nanotubular connections.  
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Figure 5. Distribution and intercellular transport of GFP-CD86 protein in macrophages and B cells. GFP-CD86 
constructs were transfected into RAW 264.7 macrophage and A20 B cells, respectively. Then cells were 
visualized under live cell conditions (37 0C, 5% CO2 atmosphere on 10 g/ml fibronectin coat) by confocal or 
SR-SIM microscopy. A: Colocalization of endogenous CD86 (labeled by anti-CD86 antibody+Alexa594-
secondary Ab; red) with transfected GFP-CD86 (green) in A20 B cells.  Panel B demonstrates that colocalization 
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of endogenous (red) and transfected GFP-CD86 (green) in Raw 264.7 macrophages is remarkable. C: 
Colocalization of GFP-CD86 (green) with Alexa647-CTX-B (red) both in B cells and macrophages could be 
observed mainly in the plasma membrane of the cells and at some points in the membrane of the nanotubes as 
shown by panels C and D. (representative CLSM images). In panels E and F colocalization of Caveolin-1 (red), 
a specific protein of caveolas with the transfected GFP-CD86 (green) demonstrates that this CD86 complexes are 
not internalized with Caveolin-mediated pathways (Pearson colocalization coefficient: -0,05867+/- 0,21603. 
showed no correlation between Caveolin-1 and GFP-CD86).Representative SR-SIM images of anti-CD86 
primary+anti-rat Alexa488 secondary antibodies labelled A20 cells before (middle) and after (right) 0.1% trypan-
blue (TB) addition demonstrate the extracellular quenching eﬀect of TB on membrane labeling, while the internal 
fluorescence was left unchanged as shown by panel G. Fig 5I clearly proves that intercellular transport of GFP-
CD86 between B cells takes place dominantly in the membrane wall of TNTs (representative, zoomed CLSM 
image; see also Supplementary Movie 5), while in macrophages it takes place dominantly within the TNT in large, 
elongated ‘microvesicle-like’ structures as shown by representative, zoomed SR-SIM image) in panel H. Panel J 
is a time lapse live cell CLSM image series about the transport of GFP-CD86 in MV-like structures, inside the 
TNTs in macrophages (see also Supplementary Movie 6).  
 
 
4. DISCUSSION 
 
Membrane nanotubes (Gerdes, Bukoreshtliev et al. 2007, Davis and Sowinski 2008) and 
extracellular vesicles (Thery, Ostrowski et al. 2009, Gyorgy, Szabo et al. 2011) are recently 
recognized novel intercellular communication/transport pathways. Their appearance and 
potential functional significance were described in many cell types of the immune- and central 
nervous systems, kidney cells or various tumor cell types (Austefjord, Gerdes et al. 2014). 
Because of their potential to control cell differentiation, survival, signal transduction, or other 
secondary cell responses, nanotubular connections gained special attention in the fields of 
immunology, neurobiology and especially in tumor biology. 
Earlier findings from our and other groups (Kabaso, Lokar et al. 2011, Lokar, Kabaso 
et al. 2012, Osteikoetxea-Molnar, Szabo-Meleg et al. 2016, Toth, Oszvald et al. 2017) showed 
that formation of nanotubes strongly depends on GM1/GM3 ganglioside and cholesterol content 
of the plasma membranes. Our recent model (Toth, Oszvald et al. 2017) proposed that the 
actual number of plasma membrane lipid rafts, as coupling sites between the plasma membrane 
and F-actin may be an essential factor determining the number of potentially outgrowing 
nanotubules. Membrane gangliosides GM1 and GM3, however, are also important in immune 
cells, as receptors of bacterial toxins, such as various enterotoxins or Cholera toxin (Holmgren 
and Lindholm 1976, Krengel and Bousquet 2014) with which they may meet frequently. 
Therefore, it is an intriguing question what happens with the target cells (such as B, T 
lymphocytes or macrophages) upon engagement of these surface gangliosides by bacterial 
toxins, such as Cholera toxin. The immature B cells (e.g. the 38C13 cell line) investigated here 
express much less gangliosides than the mature ones and could not grow nanotubes under the 
same conditions as the mature B cells did (Toth, Oszvald et al. 2017). 
 In this study we demonstrate that Cholera toxin B challenge of B cells of immature and 
mature types leads to formation of small microvesicles through internalization of GM1/GM3 
ganglioside-rich plasma membrane fractions of the cells into their cytoplasm. Internalization 
starts shortly after the CTX-B treatment and reaches its peaks after approximately 30 minutes. 
Note that the extent of internalization was different in immature and mature B cells. Immature 
B cells form much less MV structures with a lower rate than the mature ones, in accordance 
with their lower GM1/GM3 expression level (Toth, Oszvald et al. 2017) in their plasma 
membrane. However, the exact biological role and the molecular machinery of such MV-
formation still remained unclear. Nonetheless, our data highlight an important point that only 
mature B cells can respond to bacterial toxins with signaling (Schnitzler, Burke et al. 2007) 
and/or intercellular communication/microvesicle-transport. Our data also point out that such 
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difference in the plasma membrane lipid composition (in the levels of gangliosides or in other 
lipid species promoting proper membrane curvature; as reported by Toth EA et al. 2017) may 
affect not only the extent of nanotube formation, but also the subsequent microvesicle 
formation, after internalization. 
 Live cell SR-SIM superresolution imaging (Vangindertael, Camacho et al. 2018) 
technique with its improved lateral resolution (d:~ 80-90 nm) provided valuable novel 
information about the characteristic properties (e.g. morphology, size- and velocity-
distribution) of these MVs and about their transport through the TNTs connecting these 
immune cells. We demonstrated here that SR-SIM can sufficiently monitor the intercellular 
transport of these microvesicles, using both tracking and kymographic analysis of their 
motional trajectories. Analyzing their tracks and velocity distribution in the TNTs, we found 
that they move bidirectionally with a relatively low velocity (15-20 nm/s, in average). Such 
velocities suggest that they may be transported as cargos mediated by actin- or microtubule-
associated motor protein activities. Our data strongly suggest that the dominant motor protein 
mediating this transport, is the actin-dependent non-muscle myosin 2A in these cells. 
According to our results, the other abundant, microtubule-associated motor protein in B cells, 
dynein, was not involved in their transfer. This observation highlights the possibility of 
modulating such nanotubular intercellular transport e.g. by specific targeting of a motor protein 
to inhibit its cargo-transport. The low number of MVs transported intercellularly between B 
cells is likely due to the fact that adjacent B cells are often connected by more than one 
nanotube, and these can be either thin (with closed end) or thick (open ended, or tunneling) 
NTs (Osteikoetxea-Molnar et al, 2016, Cell MolLife Sci.). In contrast to the cell tracking dyes 
(DiI, DiD or DiO), staining the NTs basically uniformly, the FL-CTX-B challenge induces 
vesiculation and internalization after binding to cell surface gangliosides, regardless of the 
color of conjugated dye to CTX-B, and many of the vesicle-cargos formed this way may not 
reach the target cells because of the closed end of some NTs. 
Beyond being a ‘passive’ platform of hijacking molecules, prions, viruses or for surfing 
bacteria, membrane nanotubes may also serve as active ’communication channels’. It was e.g. 
demonstrated that immune cells can exchange protein (or lipid) molecules through the process 
called ‘trogocytosis’ that can on the other hand affect many stages of the immune response, 
e.g. effector responses of lymphocytes, cell killing, cell death/homeostasis, etc. (Onfelt, 
Nedvetzki et al. 2004, Davis and Sowinski 2008, Davis 2009).   
 The intercellular transport pathways shown here arise an important question: what 
might be the biological significance of the molecular transport across TNTs between the same 
or different cell types? So far, we know that the cells may inform each other about lack of 
energy (compensated e.g. by transfer of mitochondria) or tumor cells may transfer even 
resistance factors to each other via NTs (Osswald, Jung et al. 2015). Immune cells may transfer 
this way to each other molecules in the TNT membrane or inside the tube, packed in 
microvesicles, that may modulate (either activate or inhibit) different steps of the adaptive 
immune response (Thery, Ostrowski et al. 2009, Gyorgy, Szabo et al. 2011). Such intercellular 
transport processes described in the present study may result in the so called “cross-dressing” 
of the connected cells (Dhainaut and Moser 2014, Campana, De Pasquale et al. 2015, Zaccard, 
Watkins et al. 2015, Zaccard, Rinaldo et al. 2016), especially of antigen presenting cells 
(APCs), which may lead to a more efficient antigen presentation and T cell activation, 
important for an efficient cellular immune response.  
 Our results also pointed on the differences in intracellular compartmentation, traffic 
and intercellular transport via TNTs of the GFP-CD86 costimulatory protein in B cells vs. 
macrophages. In B cells these proteins are transported dominantly along the membrane of the 
TNTs, while in macrophages the transfected GFP-CD86 appears to form special intracellular 
compartments, in highly dense, large ‘microvesicle–like’ structures and intercellularly 
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transported in these unusual, elongated structures inside the TNTs. We do not know yet what 
is the reason of this difference, but it is likely due to the different internalization pathways, and 
intracellular protein storage/compartmentation mechanisms in macrophages and B cells, 
respectively (see e.g. the unusually high density of CD86 in the ‘microvesicle-like’ structures 
in macrophages) (Biswas, Biswas et al. 2009, Xu, Barnes et al. 2010). A dynamic intracellular 
CD86 reservoir described and characterized earlier (Smyth, Logan et al. 1998, Smyth, Logan 
et al. 2005) showing a cell-type specific subcellular compartmentation of CD86 seems to 
support our findings regarding the differences in the transportation mechnisms.  
Regardless of the exact mechanism, which obviously needs further examination, the 
presented work explored that both B cells and macrophages (as potential antigen presenting 
cells) can exchange CD86, a centrally important costimulator in T cell activation, via 
nanotubular connections. Our findings helped to reveal new aspects of intercellular transport 
of immunoregulatory factors and hence to recognize novel potential immunomodulation 
pathways. Exact identification of all the significant immunoregulatory components carried by 
the ganglioside-rich, CTX-B+ microvesicles described here, of course is another important  
task, which needs further detailed investigations. Our results otherwise also highlighted the 
power of SR-SIM (or other) superresolution imaging techniques (Vangindertael, Camacho et 
al. 2018) over live cell confocal microscopy in revealing ‘submicroscopic’ structural or kinetic 
details of novel biological transport pathway, such as microvesicle transport via intercellular 
nanotubular networks.  
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